These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Impact of PET/CT on initial staging, restaging and treatment management of anal cancer: a clinical case with literature review. Piperkova E; Raphael B; Altinyay M; Castellon I; Libes R; Sandella N; Abdel-Dayem H J BUON; 2006; 11(4):523-7. PubMed ID: 17309188 [TBL] [Abstract][Full Text] [Related]
11. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736 [TBL] [Abstract][Full Text] [Related]
12. Can the radiation dose to CT-enlarged but FDG-PET-negative inguinal lymph nodes in anal cancer be reduced? Mai SK; Welzel G; Hermann B; Wenz F; Haberkorn U; Dinter DJ Strahlenther Onkol; 2009 Apr; 185(4):254-9. PubMed ID: 19370429 [TBL] [Abstract][Full Text] [Related]
13. Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence. Asagi A; Ohta K; Nasu J; Tanada M; Nadano S; Nishimura R; Teramoto N; Yamamoto K; Inoue T; Iguchi H Pancreas; 2013 Jan; 42(1):11-9. PubMed ID: 22699206 [TBL] [Abstract][Full Text] [Related]
14. PET/CT in anal cancer - is it worth doing? Wells IT; Fox BM Clin Radiol; 2012 Jun; 67(6):535-40. PubMed ID: 22208962 [TBL] [Abstract][Full Text] [Related]
15. Staging accuracy of pancreatic cancer: comparison between non-contrast-enhanced and contrast-enhanced PET/CT. Yoneyama T; Tateishi U; Endo I; Inoue T Eur J Radiol; 2014 Oct; 83(10):1734-9. PubMed ID: 25043494 [TBL] [Abstract][Full Text] [Related]
16. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. Antoch G; Saoudi N; Kuehl H; Dahmen G; Mueller SP; Beyer T; Bockisch A; Debatin JF; Freudenberg LS J Clin Oncol; 2004 Nov; 22(21):4357-68. PubMed ID: 15514377 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of (18)F-2-deoxy-fluoro-D-glucose positron emission tomography for pN2 lymph nodes in patients with lung cancer. Ozawa Y; Hara M; Sakurai K; Nakagawa M; Tamaki T; Nishio M; Shibamoto Y Acta Radiol; 2010 Mar; 51(2):150-5. PubMed ID: 20092375 [TBL] [Abstract][Full Text] [Related]
18. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT. Yun M; Lim JS; Noh SH; Hyung WJ; Cheong JH; Bong JK; Cho A; Lee JD J Nucl Med; 2005 Oct; 46(10):1582-8. PubMed ID: 16204706 [TBL] [Abstract][Full Text] [Related]
19. [Role of 18F-FDG PET/CT in diagnosis and staging of nasopharyngeal carcinoma]. Lin XP; Zhao C; Chen MY; Fan W; Zhang X; Zhi SF; Liang PY Ai Zheng; 2008 Sep; 27(9):974-8. PubMed ID: 18799039 [TBL] [Abstract][Full Text] [Related]
20. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology. Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]